{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:39:29Z","timestamp":1789850369686,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s12325-013-0029-0","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T08:52:43Z","timestamp":1367916763000},"page":"459-471","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)"],"prefix":"10.1007","volume":"30","author":[{"given":"Yuichi","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigetake","family":"Sasayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,8]]},"reference":[{"issue":"12 Suppl S","key":"29_CR1","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/j.jacc.2004.02.033","volume":"43","author":"GG Pietra","year":"2004","unstructured":"Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):25S\u201332S.","journal-title":"J Am Coll Cardiol"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"51A","DOI":"10.1016\/S0002-9149(99)80383-X","volume":"75","author":"LJ Rubin","year":"1995","unstructured":"Rubin LJ. Pathology and pathophysiology of pulmonary arterial hypertension. Am J Cardiol. 1995;75:51A\u20134A.","journal-title":"Am J Cardiol"},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","volume":"327","author":"BW Christman","year":"1992","unstructured":"Christman BW, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 1992;327:70\u20135.","journal-title":"N Engl J Med"},{"key":"29_CR4","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","volume":"351","author":"HW Farber","year":"2004","unstructured":"Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004;351:1655\u201365.","journal-title":"N Engl J Med"},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1183\/09059180.00003309","volume":"18","author":"MA Gatzoulis","year":"2009","unstructured":"Gatzoulis MA, Alonso-Gonzalez R, Beghetti M. Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease. Eur Respir Rev. 2009;18:154\u201361.","journal-title":"Eur Respir Rev"},{"issue":"1 Suppl","key":"29_CR6","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jacc.2009.04.017","volume":"54","author":"RJ Barst","year":"2009","unstructured":"Barst RJ, Gibbs JS, Ghofrani HA, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S78\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"29_CR7","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"N Gali\u00e8","year":"2009","unstructured":"Gali\u00e8 N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493\u2013537.","journal-title":"Eur Heart J"},{"key":"29_CR8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1183\/09031936.05.00075305","volume":"26","author":"MM Hoeper","year":"2005","unstructured":"Hoeper MM, Markevych I, Spiekerkoetter E, Welte T, Niedermeyer J. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J. 2005;26:858\u201363.","journal-title":"Eur Respir J"},{"key":"29_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tcm.2009.04.003","volume":"19","author":"LE Fredenburgh","year":"2009","unstructured":"Fredenburgh LE, Ma J, Perrella MA. Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility. Trends Cardiovasc Med. 2009;19:31\u20137.","journal-title":"Trends Cardiovasc Med"},{"key":"29_CR10","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","volume":"159","author":"RM Tuder","year":"1999","unstructured":"Tuder RM, Cool CD, Geraci MW, et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med. 1999;159:1925\u201332.","journal-title":"Am J Respir Crit Care Med"},{"key":"29_CR11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.201001-0011OC","volume":"182","author":"E Falcetti","year":"2010","unstructured":"Falcetti E, Hall SM, Phillips PG, et al. Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;182:1161\u201370.","journal-title":"Am J Respir Crit Care Med"},{"key":"29_CR12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"RJ Barst","year":"1996","unstructured":"Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;334:296\u2013301.","journal-title":"N Engl J Med"},{"key":"29_CR13","unstructured":"GlaxoSmithKline. Prescribing Information: Flolan\u00ae for Injection (0.5\u00a0mg, 1.5\u00a0mg). January 2012."},{"key":"29_CR14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/DDDT.S31628","volume":"6","author":"O Lambert","year":"2012","unstructured":"Lambert O, Bandilla D. Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension. Drug Des Dev Ther. 2012;6:235\u201344.","journal-title":"Drug Des Dev Ther."},{"key":"29_CR15","doi-asserted-by":"crossref","unstructured":"Sitbon O, Delcroix M, Bergot E, et al. EPITOME-2, An open-label study evaluating a new formulation of epoprostenol sodium in pulmonary arterial hypertension patients switched from Flolan\u00ae. Am J Respir Crit Care Med. 2012; 185 A2500.","DOI":"10.1164\/ajrccm-conference.2012.185.1_MeetingAbstracts.A2500"},{"key":"29_CR16","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","volume":"43","author":"G Simonneau","year":"2004","unstructured":"Simonneau G. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43:5S\u201312S.","journal-title":"J Am Coll Cardiol"},{"key":"29_CR17","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","volume":"54","author":"G Simonneau","year":"2009","unstructured":"Simonneau G. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54:S43\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"29_CR18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/clc.4960230519","volume":"23","author":"LJ Acierno","year":"2000","unstructured":"Acierno LJ. Adolph Fick: mathematician, physicist, physiologist. Clin Cardiol. 2000;23:390\u20131.","journal-title":"Clin Cardiol"},{"key":"29_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7525-7-36","volume":"7","author":"M Bharmal","year":"2009","unstructured":"Bharmal M, Payne K, Atkinson MJ, Desrosiers MP, Morisky DE, Gemmen E. Validation of an abbreviated treatment satisfaction questionnaires for medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes. 2009;7:36.","journal-title":"Health Qual Life Outcomes."},{"key":"29_CR20","doi-asserted-by":"crossref","first-page":"e52216","DOI":"10.1371\/journal.pone.0052216","volume":"7","author":"Y Tamura","year":"2012","unstructured":"Tamura Y, Nakajima Y, Ozeki Y, et al. Temperature variations around medication cassette and carry bag in routine use of epoprostenol administration in healthy volunteers. PLoS ONE. 2012;7:e52216.","journal-title":"PLoS ONE"},{"key":"29_CR21","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0140-6736(11)60672-7","volume":"377","author":"Y Tamura","year":"2011","unstructured":"Tamura Y, Fukuda K. Earthquake in Japan. Lancet. 2011;377:1652.","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1007\/s12325-013-0031-6","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,5,25]],"date-time":"2013-05-25T00:00:00Z","timestamp":1369440000000}}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-013-0029-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T09:26:52Z","timestamp":1563010012000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-013-0029-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s12325-013-0029-0","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s12325-013-0031-6","asserted-by":"object"}]},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}